COMPANY
Biolinq Inc.
Funding and NIH signals
- NIH award NIH awarded $862K (SBIR Phase II 5R44DK129875-05, continuation, notice Jun 11, 2026). NIH RePORTER 5R44DK129875-05 (Jun 11, 2026)
Evidence (1 event)
- Jun 11, 2026 · NIH RePORTER 5R44DK129875-05
Organization: BIOLINQ INCORPORATED; City/State: San Diego, CA; Project number: 5R44DK129875-05; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-11; FY total cost (award amount): 861567; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes; Organization type: Domestic For-Profits
- Jun 11, 2026 · NIH RePORTER 5R44DK129875-05
Raises and deals from press releases
- Raise Series C · $100M · announced Apr 22, 2025 Company release ↗
Source quote
- Apr 22, 2025 · Company release ↗
“Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health”
- Apr 22, 2025 · Company release ↗
Timeline
- Grant Government grant — SBIR: $861,567 (annual award, as published), announced Jun 11, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
- Grant Government grant — SBIR: $853,587 (annual award, as published), announced Jun 12, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗
- Raise Series C · $100M source ↗
Funding
- Government grant — SBIR: $861,567 (annual award, as published), announced Jun 11, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
- Government grant — SBIR: $853,587 (annual award, as published), announced Jun 12, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗
NIH awards 12
- NIH award 5R44DK129875-03 FY2023: $786,397 awarded for that fiscal year; activity R44 (SBIR); PI TANGNEY, JARED RYLAN; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. A Hybrid Continuous Glucose and Lactat source ↗
- NIH award 4R44DK129875-02 FY2022: $798,715 awarded for that fiscal year; activity R44 (SBIR); PI TANGNEY, JARED RYLAN; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. A Hybrid Continuous Glucose and Lactat source ↗
- NIH award 1R44DK129875-01 FY2021: $299,340 awarded for that fiscal year; activity R44 (SBIR); PI TANGNEY, JARED RYLAN; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. A Hybrid Continuous Glucose and Lactat source ↗
- NIH award 5R44AA024643-03 FY2017: $499,928 awarded for that fiscal year; activity R44 (SBIR); PI WINDMILLER, JOSHUA RAY; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. Wearable Biosensors for Real-time Bl source ↗
- NIH award 4R44AA024643-02 FY2016: $495,958 awarded for that fiscal year; activity R44 (SBIR); PI WINDMILLER, JOSHUA RAY; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. Wearable Biosensors for Real-time Bl source ↗
- NIH award 1R44AA024643-01 FY2015: $181,913 awarded for that fiscal year; activity R44 (SBIR); PI WINDMILLER, JOSHUA RAY; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. Wearable Biosensors for Real-time Bl source ↗
- NIH award 5R43DK103559-02 FY2015: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI WINDMILLER, JOSHUA RAY; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. Microneedle-based Transdermal Sensin source ↗
- NIH award 5R43AG048626-02 FY2015: $181,424 awarded for that fiscal year; activity R43 (SBIR); PI WINDMILLER, JOSHUA RAY; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. Non-invasive Continuous Hydration Mo source ↗
- NIH award 5R43DK097989-03 FY2014: $181,115 awarded for that fiscal year; activity R43 (SBIR); PI WINDMILLER, JOSHUA RAY; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. Microneedle arrays for non-invasive source ↗
- NIH award 1R43AG048626-01 FY2014: $210,374 awarded for that fiscal year; activity R43 (SBIR); PI WINDMILLER, JOSHUA RAY; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. Non-invasive Continuous Hydration Mo source ↗
- NIH award 1R43DK103559-01 FY2014: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI WINDMILLER, JOSHUA RAY; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. Microneedle-based Transdermal Sensin source ↗
- NIH award 7R43DK097989-02 FY2013: $179,611 awarded for that fiscal year; activity R43 (SBIR); PI WINDMILLER, JOSHUA RAY; recipient as written: BIOLINQ INCORPORATED, San Diego, CA. Microneedle arrays for non-invasive source ↗
Connect
See your connections at Biolinq on LinkedIn (search by name, results not checked)